The present invention provides transient receptor potential vanilloid (TRPV) modulators of formula (I). In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
[EN] CHROMENONE DERIVATIVES AS TRPV3 ANTAGONISTS<br/>[FR] DÉRIVÉS DE CHROMÉNONE CONVENANT COMME ANTAGONISTES DE TRPV3
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2010055384A1
公开(公告)日:2010-05-20
The present invention provides transient receptor potential vanilloid (TRPV) modulators of formula (I). In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRP V3. (Formula I) (I)